This mechanism was utilized for the conditional activation of PKR-mediated cell death via a duplex consisting of the Bcr/Abl fusion oncogene (typical for chronic myelogenous leukemia) and an exogenous designed cognate antisense strand [35]. Here, EIF2AK2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.